Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.Circulation. 1991; 83: 1294-1304
Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial: writing group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. JAMA 1997;277:715–721.
- The Lipid Treatment Assessment Project (L-TAP).Arch Intern Med. 2000; 160: 459-467
Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S, for the HERS Research Group. Adherence to National Cholesterol Education Program treatment goals in post-menopausal women with heart disease: The Heart and Estrogen/Progestin Replacement Study (HERS). Jama 1997;277:1281–1286.
- Analysis of the degree of undertreatment of dyslipidemia and congestive heart failure secondary to coronary artery disease.Am J Cardiol. 1999; 83: 1303-1307
The Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015–3023.
- The nurse-practitioner’s role in complex patient management.J Natl Med Assoc. 1983; 75: 1197-1220
- A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus.J Gen Intern Med. 1995; 10: 59-66
- Smoking cessation after acute myocardial infarction.Ann Intern Med. 1990; 113: 118-1123
- Treatment of hypercholesterolemia by a clinical nurse using a stepped-care protocol in a non-volunteer population.Arch Intern Med. 1988; 148: 1046-1048
- A case management system for coronary risk factor modification after acute myocardial infarction.Ann Intern Med. 1994; 120: 721-729
PCS (Prescription Card Services) Health Systems Inc. Minneapolis; June, 1998.
Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Kiratzka LF, Houston-Miller M, Kris-Etherton P, Krumholz HM, LaRosa J, et al. When to start cholesterol-lowering therapy in patients with coronary artery disease: a statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. Circulation 1997;95:1683–1685.
Fonarow C, Gawlinski A, Cardin S, Moughrabi S, Tillisch JI. Improved treatment of cardiovascular disease by implementation of a cardiac hospitalization atherosclerosis management program: CHAMP. Circulation 1997;96(suppl):67.
Patient Compliance: Lipid Lowering Agents TOP Study. Merck & Co. Inc.; 1992.
Kos Pharmaceuticals, Inc. Unpublished data on file.